CNP shorts at a one-year high with earnings six days out

CenterPoint Energy enters its October 27 results with short interest at its highest level in more than a year, a detail that matters given the stock has spent much of 2026 underperforming its regulated utility peers.

Short interest has climbed to 7.6% of the free float, up 12% over the past month and the highest reading in the 30-day history visible in the data. The build has been steady rather than violent: from roughly 40.9 million shares in early September to 49.4 million today. Despite that accumulation, the borrow market remains relaxed. Cost to borrow is just 0.52%, barely changed from a month ago, and availability is ample at around 500% of shares already borrowed, meaning there is no shortage of stock to lend and no mechanical pressure on the short side. The ORTEX short score of 56.8 has drifted up slightly over the past two weeks but stays in the middle of its range, far from the extremes that would signal a crowded trade. This is a measured increase in bearish positioning, not a squeeze setup.

Options positioning tells an even more bullish story, and that contrast is worth naming. The put/call ratio dropped to 0.15 on Tuesday, its lowest reading of the past 52 weeks. That is more than 1.4 standard deviations below the 20-day average of 0.19. Call demand has overwhelmed put buying at exactly the moment short sellers are at their peak position. Whether that reflects hedging activity, income strategies, or genuine directional optimism is unclear from the data alone, but the divergence between rising short interest and extreme call skew is the most unusual feature of this week's setup.

The Street has spent the past two weeks trimming price targets without changing its directional view. Multiple firms cut targets into the $43 to $45 range from prior levels of $46 to $48, reflecting what the bear case describes as slower Houston load growth, the pending Ohio gas utility sale, and ongoing credit pressure from Moody's and S&P. Morgan Stanley raised its target marginally to $39 this week while holding at Equal-Weight, a reminder that the neutral camp sees limited upside at current levels. The mean analyst target is $43.82, implying about 9% above the current price of $40.24. The bull case points to 8% weather-adjusted commercial and industrial sales growth year to date and an FFO-to-debt ratio of 14.1%, within the company's own 14% to 15% target range. On valuation, the stock trades at roughly 19.6x earnings and 10.8x EV/EBITDA, with both multiples nudging up over the past month as the share price has recovered 5.3%. The dividend score ranks in the 94th percentile of the universe, reflecting the income profile typical of regulated utilities.

CNP has risen 2.2% over the past week, nearly in line with the peer median. Close peers WEC, NI, and CMS gained 2.7%, 3.1%, and 3.2% respectively, putting CNP slightly behind on the week despite its stronger monthly performance. That mild lag against the peer group echoes a pattern noted in prior notes: CNP has spent much of 2026 at the soft end of the regulated utility pack. Capital Research Global Investors has continued building, crossing 10% of the class in its latest 13G filing, and T. Rowe Price stands at 10.2%. No 13D activist is on the register, and the institutional activity reflects portfolio accumulation rather than pressure from a campaigning shareholder.

The earnings release on October 27 is the natural focal point. The last two quarterly reports each produced a negative one-day reaction, with the most recent July print down 2.5% on the day and 5.5% over the following week. With short interest at a 12-month high and call activity at a 52-week extreme, the reaction to management's updated guidance on the Ohio sale and Houston demand trajectory will be the number that resolves the current tension between these two camps.